Scottish researchers who are currently hoping to develop synthetic human blood have been given a license to use stem cells to manufacture the blood.
Researchers at the Scottish National Blood Transfusion Service, Edinburgh University and Roslin Cells have been granted the license by UK's Medicines and Healthcare products Regulatory Agency (MHRA), taking them another step closer to conducting clinical trials to test the synthetic blood.
Advertisement
The study is being conducted at the Scottish Centre for Regenerative Medicine (SCRM) and the researchers hope to manufacture blood that could eventually be used in humans, overcoming the supply shortages.
Roslin Cells' chief operating officer, Janet Downie welcomed the decision by MHRA and said, "Attaining these licences has been a key goal for the Scottish Centre for Regenerative Medicine and we are delighted to have reached this important milestone."
Source: Medindia
Source: Medindia
Advertisement
Bone Marrow Aspiration and Biopsy
Bone marrow biopsy and aspiration is the removal of some bone marrow tissue for diagnosis and management of cancers of blood cells and multiple myeloma.
Advertisement
Latest Genetics & Stem Cells News
Can stem cell therapy cure fistula? Yes, treatment with stem cells has had a success rate when used in perianal fistulas due to Crohn's Disease.
In zebrafish models of SURF1 mitochondrial disease, scientists have discovered drugs to prevent neurological decompensation.
New study advances intravitreal gene therapy platform to develop safe and effective therapies for visual loss in Usher Syndrome, rare disorder.
The study experiments shed light on a rare example of how autism-associated mutation could altered nuclear dynamics.
A genotype-first approach to patient care involves selecting patients with specific genomic variants and then studying their traits and symptoms.
